ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

23,00
0,00
(0,00%)
Fermé 02 Décembre 5:30PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
23,00
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
23,00 Plage de 52 semaines 23,00
Cap du marché
Clôture Veille
23,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 201
Actions en circulation
657 954 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-60,88
Bénéfice par action (BPA)
-0,38
Chiffre d'affairess
59,27M
Bénéfice net
-248,59M

À propos de Alligator Bioscience Ab

Secteur
Noncomml Resh Organizations
Industrie
Noncomml Resh Organizations
Siège social
Lund, Swe
Fondé
-
Alligator Bioscience Ab est coté dans le secteur Noncomml Resh Organizations de la London Stock Exchange avec le ticker 0RK9. Le dernier cours de clôture d'Alligator Bioscience Ab était de SEK23,00. Au cours de la dernière année, les actions de Alligator Bioscience Ab ont été négociées dans une fourchette de prix de SEK 23,00 à SEK 23,00.

Alligator Bioscience Ab compte actuellement 657 954 000 actions en circulation. La capitalisation boursière d'Alligator Bioscience Ab est de SEK15,13 milliard. Alligator Bioscience Ab a un ratio cours/bénéfice (ratio PE) de -60.88.

0RK9 Dernières nouvelles

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
100232323276823DE
400232323540123DE
1200232323220123DE
2600232323152123DE
5200232323224423DE
15600232323141823DE
26000232323167223DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
0
0A1UUber Technologies Inc
US$ 72,15
(0,00%)
2,94k
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
0
0A1UUber Technologies Inc
US$ 72,15
(0,00%)
2,94k
0R0XTesla Inc
US$ 339,20
(0,00%)
15,78k
0A6LGamestop Corp
US$ 29,9025
(0,00%)
3,44k
0HCIAlibaba Group Holding Ltd
US$ 86,90
(0,00%)
3,07k
0A1UUber Technologies Inc
US$ 72,15
(0,00%)
2,94k
0R1OAmazon.com Inc
US$ 206,00
(0,00%)
1,93k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock